Rush for diabetes and weight-loss drug Ozempic puts cross-border sales in spotlight
The Canadian Pharmacists Association says protecting Canadian drug supplies from mass exportation to the U.S. market remains a priority in light of British Columbia's recent move to limit sales of the diabetes drug Ozempic, which has been hyped as a weight-loss treatment.
